NASDAQ:GMAB
USD
27.72
- (-3.6%)
GENMAB A/S
Industry: Biotechnology
End of Day: 2 May 2024 GMT-4
USD 27.72
- (-3.6%)
End of Day: 2 May 2024 GMT-4
Industry: Biotechnology
Quote
Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-
Company Info
more
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab’s proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and...
Key Ratios
more
Income
more
Total Revenues (DKK, MM)
-
Net Income (DKK, MM)
-
Net Margin
-
Balance Sheet
more
Total Assets (DKK, MM)
-
Total Liabilities (DKK, MM)
-
Book Value Per Share
-
Cash Flow
more
Operations (DKK, MM)
-
Investing (DKK, MM)
-
Financing (DKK, MM)
-
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
